MX354316B - Pharmaceutical composition with an antihypertensive and diuretic. - Google Patents

Pharmaceutical composition with an antihypertensive and diuretic.

Info

Publication number
MX354316B
MX354316B MX2012011902A MX2012011902A MX354316B MX 354316 B MX354316 B MX 354316B MX 2012011902 A MX2012011902 A MX 2012011902A MX 2012011902 A MX2012011902 A MX 2012011902A MX 354316 B MX354316 B MX 354316B
Authority
MX
Mexico
Prior art keywords
pharmaceutically acceptable
liquid
agents
pharmaceutical composition
diuretic
Prior art date
Application number
MX2012011902A
Other languages
Spanish (es)
Other versions
MX2012011902A (en
Inventor
Barranco Hernández Gustavo
Senosiain Arroyo Héctor
Del Coral Luna Guiza Maria
Original Assignee
Laboratorios Senosiain S A De C V Star
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51213229&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX354316(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Senosiain S A De C V Star filed Critical Laboratorios Senosiain S A De C V Star
Priority to MX2012011902A priority Critical patent/MX354316B/en
Priority to PE2013002275A priority patent/PE20141320A1/en
Priority to BR102013026288-9A priority patent/BR102013026288B1/en
Publication of MX2012011902A publication Critical patent/MX2012011902A/en
Publication of MX354316B publication Critical patent/MX354316B/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention refers to a novel pharmaceutical composition in water-free liquid forms contained in a hard gelatin capsule and/or soft gelatin capsule, which consists in a) a pharmaceutically acceptable amount of one or more antihypertensive agents of angiotensin II receptor antagonist in combination with, b) a pharmaceutically acceptable amount of one or more diuretic agents, c) at least an agent for increasing the solubility of the active principles, d) at least an alkaline agent, e) at least an antioxidant and/or preserver, f) at least a pharmaceutically acceptable vehicle and/or at least a pharmaceutically acceptable excipient; all agents are contained in an oral administration system which contains one or more phases that are not limited to: liquid-liquid, liquid-solid, which is used for the treatment and/or control of hypertension and/or associated disorders.
MX2012011902A 2012-10-12 2012-10-12 Pharmaceutical composition with an antihypertensive and diuretic. MX354316B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
MX2012011902A MX354316B (en) 2012-10-12 2012-10-12 Pharmaceutical composition with an antihypertensive and diuretic.
PE2013002275A PE20141320A1 (en) 2012-10-12 2013-10-11 PHARMACEUTICAL COMPOSITION WITH AN ANTIHYPERTENSIVE AND A DIURETIC
BR102013026288-9A BR102013026288B1 (en) 2012-10-12 2013-10-11 PHARMACEUTICAL COMPOSITION WITH AN ANTIHYPERTENSIVE AND DIURETIC

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012011902A MX354316B (en) 2012-10-12 2012-10-12 Pharmaceutical composition with an antihypertensive and diuretic.

Publications (2)

Publication Number Publication Date
MX2012011902A MX2012011902A (en) 2014-04-28
MX354316B true MX354316B (en) 2018-02-26

Family

ID=51213229

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012011902A MX354316B (en) 2012-10-12 2012-10-12 Pharmaceutical composition with an antihypertensive and diuretic.

Country Status (3)

Country Link
BR (1) BR102013026288B1 (en)
MX (1) MX354316B (en)
PE (1) PE20141320A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11878022B2 (en) 2020-12-10 2024-01-23 Novitium Pharma LLC Hydrochlorothiazide compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11878022B2 (en) 2020-12-10 2024-01-23 Novitium Pharma LLC Hydrochlorothiazide compositions

Also Published As

Publication number Publication date
BR102013026288A2 (en) 2015-08-04
BR102013026288B1 (en) 2020-08-04
MX2012011902A (en) 2014-04-28
PE20141320A1 (en) 2014-10-17

Similar Documents

Publication Publication Date Title
MX2016006053A (en) Selective pyy compounds and uses thereof.
MX2017004592A (en) Pharmaceutical formulations for the oral delivery of peptide or protein drugs.
PH12015501595A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
PE20181523A1 (en) TREATMENT OF LUPUS NEFRITIS USING LAQUINIMOD
PH12015501598A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
MX2017015105A (en) Selective pyy compounds and uses thereof.
PH12015501600A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
MY188450A (en) Spiro-lactam nmda receptor modulators and uses thereof
SG10201810985XA (en) Tofacitinib oral sustained release dosage forms
MY160728A (en) Morpholinothiazoles as alpha 7 positive allosteric modulators
CO2017012670A2 (en) Orodispersible dosing unit containing an estetrol component
MA34083B1 (en) PHARMACEUTICAL COMPOSITIONS OF SPIRO-OXINDOLE COMPOUND FOR TOPICAL ADMINISTRATION AND USE THEREOF AS THERAPEUTIC AGENTS
GT201700270A (en) ORODISPERSABLE DOSING UNIT CONTAINING A STETROL COMPONENT
MY160652A (en) Pharmaceutical composition for oral administration
EA201990249A1 (en) APPLICATION AND DOSAGE MODE OF THERAPEUTIC AGENTS IN ENDOMETRIOSIS
MX2013001637A (en) Oral controlled release pharmaceutical compositions of blonanserin.
EA201590474A1 (en) PHARMACEUTICAL COMPOSITION BASED ON COMPOSITE CAPSULES INCLUDING IRBESARTAN AND HMG-COA REDUCTASE INHIBITOR
MX2012011902A (en) Pharmaceutical composition with an antihypertensive and diuretic.
MX2018013969A (en) Combination of pure 5-ht6 receptor antagonists with nmda receptor antagonist.
NZ764004A (en) Heteroaryl compounds as muscarinic m1 receptor positive allosteric modulators
MX356245B (en) Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimet hyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and a gabapentinoid.
WO2020013776A3 (en) Synergistic effect of naproxen and a gastro protective agent for the treatment of pain and inflammation
MX345469B (en) Combination of (3s,3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent.
EA201590732A1 (en) DISPENSABLE TABLET
TR201008460A1 (en) Sachet formulations of eslicarbazepine.

Legal Events

Date Code Title Description
FG Grant or registration